High neutrophil-to-lymphocyte ratio before starting anti-programmed cell death 1 immunotherapy predicts poor outcome in patients with metastatic melanoma

MeSH terms

• Aged
• Analysis of Variance
• Biomarkers, Tumor / blood
• Cohort Studies
• Female
• France
• Humans
• Immunotherapy / methods*
• Lymphocyte Count
• Lymphocytes / cytology
• Male
• Melanoma / drug therapy*
• Melanoma / mortality*
• Melanoma / pathology
• Middle Aged
• Multivariate Analysis
• Neoplasm Invasiveness / pathology
• Neoplasm Metastasis
• Neoplasm Staging
• Neutrophils / cytology
• Patient Selection
• Prognosis
• Programmed Cell Death 1 Receptor / administration & dosage*
• Retrospective Studies
• Risk Assessment
• Skin Neoplasms / drug therapy*
• Skin Neoplasms / mortality*
• Skin Neoplasms / pathology
• Survival Analysis
• Treatment Outcome